相关实验视频
Updated: May 17, 2025
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.4K
在复杂的成人先天性心脏病中管理心力衰竭
Tzvi Fishkin1, Ashish Tripathi1, Muhammad Furqan1
1From the Department of Medicine, Westchester Medical Center, Valhalla, NY.
Cardiology in review
|May 14, 2025
概括
患有复杂先天性心脏病的成年人面临心力衰竭的高发率. 由于独特的解剖学和生理学,管理需要量身定制的策略,需要对有效的医学疗法进行更多研究.
科学领域:
- 心脏病学 心脏病学
- 儿童心脏病学 儿童心脏病学
- 成年人的先天性心脏病
背景情况:
- 复杂先天性心脏病 (CCHD) 管理已经取得了进展,使得更多的儿童能够活到成年.
- 这种不断增长的人口通常具有复杂的解剖学和生理学,导致心力衰竭 (HF) 的高患病率.
- 患有慢性心血管疾病的成年人中的HF不同于一般成年人群中的HF.
研究的目的:
- 审查目前对患有复杂先天性心脏病的成年人心力衰竭的理解.
- 突出在这个人群中管理高压的独特挑战.
- 识别知识缺口和未来研究领域.
主要方法:
- 关于患有慢性心脏病的成人心力衰竭研究的文献综述.
- 分析当前的管理指南和治疗选择.
- 综合关于CCHD和息手术对HF发展的影响数据.
主要成果:
- 患有慢性心血管疾病的成年人患有渐进性心力衰竭的发病率很高.
- 慢性心血管疾病的解剖和生理后果及其手术缓解有助于HF.
- 目前的管理策略需要根据独特的患者个人资料进行调整.
- 关于改善症状负担和死亡率的医学治疗方法的数据有限.
结论:
- 心力衰竭是患有慢性心脏病的成年人的一个显著和渐进的问题.
- 管理必须是个性化的,考虑到独特的解剖学和生理学.
- 进一步的研究和大规模试验对于优化这种人群中HF治疗至关重要.
- 像机械循环支持和移植这样的先进疗法通常是缺乏补偿的HF所必需的.
相关概念视频
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:26Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
334
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
334
01:22Heart Failure Drugs: Diuretics
298
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
01:26Heart Failure Drugs: Inotropic Agents
451
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
451
01:22Heart Failure Drugs: β-Blockers
287
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
287